Dr. Markus Yashavant Mapara, MD
- Medicare services, 2024
- 244
- Medicare patients, 2024
- 49
- Part D claims, 2024
- 16
- Publications
- 65
- Clinical trials
- 2
- Practice address
- 622 W 168th St, New York, NY 10032
- Practice phone
- Call (212) 297-4255
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Columbia University Irving Medical Center
New York, New York
Find Dr. Mapara's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Markus Yashavant Mapara is a medical oncologist in New York, New York
Dr. Mapara practices at Columbia University Irving Medical Center in New York, New York.
Dr. Mapara's NPI, 1093786766, was assigned on January 30, 2006. Dr. Mapara graduated from University of Heidelberg Faculty of Medicine in 1990. Dr. Mapara holds New York license 263243.
- NPI
- 1093786766NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4688688930
- NPI enumeration date
- January 30, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (212) 297-4255
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 62
- Medical school graduation
- 1990
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Markus Yashavant Mapara practices at Columbia University Irving Medical Center in New York, New York
Dr. Mapara's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.
- Columbia University Irving Medical Center622 W 168th St, New York, NY 10032 · New York CountyPhone(212) 297-4255
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Markus Yashavant Mapara is affiliated with 4 sites of care and 2 medical groups
Dr. Mapara's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Mapara is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Mapara to 2 more group practices and clinics and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Markus Yashavant Mapara's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mapara practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Columbia University Irving Medical Center | Available with a free account |
| +3 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Markus Yashavant Mapara is one of 458 medical oncologists in New York
Medical oncology is Dr. Mapara's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Mapara is board certified in hematology/oncology by the Internal Medicine. Dmand AI has Dr. Mapara's licenses on file in 2 states: New York and Pennsylvania.
Specialties and state licenses
- Medical oncology, New YorkPrimary
- Pennsylvania license
Clinical focus
Dmand AI lists acute respiratory failure, chronic diabetes and gastrointestinal infection among the conditions Dr. Mapara treats.
Medical oncologists near Dr. Mapara
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Markus Yashavant Mapara billed Medicare for 244 services in 2024
CMS data shows 244 Medicare services from Dr. Mapara across 3 procedure codes in 2024, for 49 Medicare patients. Medicare paid $25,897 for them.
Dr. Mapara's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2462024: 18923%
- Other services
- 2023: 02024: 55
Where Dr. Mapara's Medicare services took place, 2024
- In an office16568%
- In a facility7932%
Dr. Mapara compared with the New York median for medical oncologists, 2024
- Dr. Mapara
- New York median
- Medicare services
- 244vs 34028% below
- Medicare patients
- 49vs 11256% below
- Part D claims
- 12vs 13091% below
Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.
Dr. Mapara's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mapara?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mapara and other medical oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Markus Yashavant Mapara treated 49 Medicare patients in 2024, average age 64
CMS counts 49 Medicare patients who saw Dr. Mapara in 2024. The largest group is 65 to 74, with 29 patients. 69% of them have high blood pressure, and 63% have high cholesterol. 27% are also on Medicaid. Their average risk score is 3.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mapara's median patient age at 69, with 43% women.
Dr. Mapara's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Mapara's Medicare patients by sex, 2024
- Women2143%
- Men2857%
Chronic conditions among Dr. Mapara's Medicare patients, 2024
- High blood pressure69%
- High cholesterol63%
- Arthritis51%
- Diabetes45%
- Chronic kidney disease41%
- Anxiety31%
- Mood disorders31%
- Ischemic heart disease29%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mapara's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women43%
- Men57%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Markus Yashavant Mapara wrote 16 Medicare Part D claims in 2024
In 2024, Dr. Mapara wrote 16 Medicare Part D claims. 75% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $8,852 in total drug cost. In 2019, CMS named 23 claims across 1 drug.
Dr. Mapara's Part D claims by kind of drug, 2024
- Generic12 claims75%
- Brand-name and other4 claims25%
Dr. Mapara's most prescribed drugs by claims, 2021
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2021
- 2019
- 2021
- Claims for drugs CMS names
- 2019: 232021: 1248%
Drugs named by CMS: 1 in 2021, 1 in 2019.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Markus Yashavant Mapara scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mapara for performance year 2024, reported through an alternative payment model (APM). Dr. Mapara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mapara as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Mapara's MIPS scores, performance year 2024
- 100of 100Final score
- 85.3of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Markus Yashavant Mapara has 65 publications on record
Dmand AI links 65 papers to Dr. Mapara, published from 2005 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Hematopoietic Stem Cell Transplantation, Multiple Myeloma and Immunoglobulin Light-chain Amyloidosis. Dr. Mapara has published most often in Blood. Dr. Mapara's most frequent co-authors are Suzanne Lentzsch, MD, Divaya Bhutani, MD and Mathew Shane Maurer, MD.
Dr. Mapara's papers by year, 2013 to 2025
Topics Dr. Mapara writes about most
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma
- Immunoglobulin Light-chain Amyloidosis
- Anemia, Sickle Cell
- Antibodies, Monoclonal
- Antineoplastic Combined Chemotherapy Protocols
- Signal Transduction
- Thalidomide
Dr. Mapara's most frequent co-authors
- Suzanne Lentzsch, MD27 shared papers
- Divaya Bhutani, MD14 shared papers
- Mathew Shane Maurer, MD11 shared papers
Recent publications by Dr. Mapara
Bone Marrow Transplant
See who Dr. Mapara researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mapara works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Markus Yashavant Mapara has worked on 2 clinical trials
Dmand AI links Dr. Mapara to 2 clinical trials. Conditions studied include Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lymphoma, Non-Hodgkin and Lymphoma.
Clinical trials with Dr. Mapara by phase
- 1Phase 1: 1 trial
- NonePhase 2: no trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Mapara's trials
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Lymphoma, Non-Hodgkin
- Lymphoma
- Myeloproliferative Disorders
Investigators on the most trials with Dr. Mapara
- Nam Hoang Dang, MD1 shared trial
- John F. Dipersio, MD1 shared trial
- Andres Forero-Torres, MD1 shared trial
Recent clinical trials with Dr. Mapara
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) (opens in a new tab)
Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Markus Yashavant Mapara received $46,637 in industry payments from 2016 to 2025
CMS Open Payments shows 58 general payments to Dr. Mapara from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Incyte Corporation paid the most, $25,344.
General payments to Dr. Mapara by program year, 2016 to 2025
General payments to Dr. Mapara by kind, 2016 to 2025
- Consulting fees$36,56378%
- Travel and lodging$4,1779%
- Honoraria$3,2007%
- Food and beverage$2,6976%
Companies that paid Dr. Mapara the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Markus Yashavant Mapara graduated from University of Heidelberg Faculty of Medicine
Dr. Mapara graduated from University of Heidelberg Faculty of Medicine in 1990. Dr. Mapara is a member of American Society of Blood and Marrow Transplantation and ASH.
- Medical school
- Board certified in hematology/oncology
Source: Dmand AI Professional Profile Data
Dr. Markus Yashavant Mapara accepts plans from 11 insurance carriers
Dr. Mapara is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Aetna
- Elevance
- United Healthcare
- Blue Cross Blue Shield of Massachusetts
- Blue Cross Blue Shield of Michigan
- Cigna
- HCSC
- MVP Health Care
- +3 more carriersWith a free account
Plan types Dr. Mapara accepts, by number of carriers
- PPO9
- Medicare8
- POS4
- EPO3
- HMO3
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Markus Yashavant Mapara's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Markus Yashavant Mapara
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Markus Yashavant Mapara's NPI number?
Dr. Markus Yashavant Mapara's NPI number is 1093786766. It was assigned on January 30, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Markus Yashavant Mapara?
Dr. Markus Yashavant Mapara is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Markus Yashavant Mapara practice?
Dr. Mapara practices at 622 W 168th St, New York, NY 10032. Dr. Mapara's primary practice is Columbia University Irving Medical Center in New York, New York. Dmand AI also links Dr. Mapara to 2 group practices and clinics and 1 medical group.
What is Dr. Markus Yashavant Mapara's office phone number?
The practice phone on file for Dr. Mapara is (212) 297-4255.
What is Dr. Markus Yashavant Mapara's medical license number?
Dr. Mapara holds New York license 263243, one of the licenses on file in 2 states.
Which states has Dr. Markus Yashavant Mapara been licensed in?
Dmand AI has state licenses on file for Dr. Mapara in New York (2011 to 2027) and Pennsylvania (2005 to 2014).
Which hospitals is Dr. Markus Yashavant Mapara affiliated with?
Dr. Mapara is affiliated with NewYork-Presbyterian/Weill Cornell Medical Center.
What medical group is Dr. Markus Yashavant Mapara part of?
Dr. Mapara is linked to ColumbiaDoctors. Dmand AI links Dr. Mapara to 1 more medical group.
Does Dr. Markus Yashavant Mapara accept Medicare?
Yes. CMS data shows Dr. Mapara billed Medicare for 244 services in 2024, and Dr. Mapara accepts Medicare assignment.
Does Dr. Markus Yashavant Mapara offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Mapara as offering telehealth services.
Show 11 more questionsShow fewer questions
What is Dr. Markus Yashavant Mapara's MIPS score?
Dr. Mapara's MIPS final score for performance year 2024 is 100 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Markus Yashavant Mapara see?
CMS counts 49 Medicare patients who saw Dr. Mapara in 2024, with an average age of 64.
Is Dr. Markus Yashavant Mapara board certified?
Yes. Dr. Mapara is board certified in hematology/oncology by the Internal Medicine.
What services does Dr. Markus Yashavant Mapara bill to Medicare?
In 2024, Dr. Mapara's most billed Medicare services were office visit, established patient (99215), hospital inpatient care (99233) and medicare service (G2211).
Where did Dr. Markus Yashavant Mapara go to medical school?
Dr. Mapara graduated from University of Heidelberg Faculty of Medicine in 1990.
What drugs does Dr. Markus Yashavant Mapara prescribe most?
In 2021 Medicare Part D data, Dr. Mapara's most prescribed drugs by claims were Entecavir.
Has Dr. Markus Yashavant Mapara received payments from drug or device companies?
CMS Open Payments shows $46,637 in general payments to Dr. Mapara from 11 companies from 2016 to 2025. The largest total came from Incyte Corporation.
How long has Dr. Markus Yashavant Mapara been practicing?
Dr. Mapara graduated from medical school in 1990, 36 years ago.
Does Dr. Markus Yashavant Mapara do research?
Dmand AI links 65 publications to Dr. Mapara, published from 2005 to 2025. Dr. Mapara has worked on 2 clinical trials.
Who does Dr. Markus Yashavant Mapara publish with?
Dr. Mapara's most frequent co-authors are Suzanne Lentzsch, MD (27 shared papers), Divaya Bhutani, MD (14 shared papers) and Mathew Shane Maurer, MD (11 shared papers).
What insurance does Dr. Markus Yashavant Mapara accept?
Dr. Mapara is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card